Will Lewis, Insmed CEO, joins 'Fast Money' to talk Insmed's rare gene therapy development, demand, and quarterly results.

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

Low Vitamin D levels are a growing concern for fertility. Research shows a strong link between deficiency and reduced success ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...

Suwannee County man is behind bars in connection with a stabbing that left his father dead and his mother injured last ...

The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives. United ...

Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...

The first pig kidney transplant has begun, testing gene-edited pig kidneys. The road to these xenotransplants has been long, and it’s taken decades of research to get to the point where there are now ...

The injuries are piling up for the Bears and the latest one means Ryan Poles will need real help at one position via trade.